CEDUR - German IBD Registry
NCT07319442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-01-06
Summary
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Conditions
- Ulcerative Colitis (UC)
- Indeterminate Colitis
- Crohn Disease (CD)
Sponsors & Collaborators
-
ImmunoRegister gUG
lead OTHER
Principal Investigators
-
Stefanie Howaldt, MD · ImmunoRegister gUG
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-03
- Primary Completion
- 2036-05-31
- Completion
- 2036-05-31
Countries
- Germany
Study Locations
More Related Trials
-
Observational Investigation of the CDED in a Real World IBD Clinic
NCT05554445 ·Status: UNKNOWN
-
Crohn's Disease Endoscopic REmission Definition in an Objective Way
NCT03498625 ·Status: COMPLETED ·Phase: NA
-
MR Assessment of Perianal Crohn's Disease
NCT03325582 ·Status: UNKNOWN
-
Inflammatory Bowel Diseases Remission Registry
NCT04912999 ·Status: RECRUITING
-
Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)
NCT00705614 ·Status: COMPLETED
-
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403 ·Status: COMPLETED
-
Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients
NCT06324591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Inflammatory Bowel Disease Research Registry
NCT00574028 ·Status: COMPLETED
-
Characterization of CD Responders to Vedolizumab
NCT04909359 ·Status: COMPLETED
-
Magnetic Resonance Enterography in Inflammatory Bowel Diseases
NCT04324632 ·Status: UNKNOWN
-
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
NCT02622139 ·Status: COMPLETED ·Phase: NA
-
RED-FLAGS Index Validation in Crohn's Disease Patients
NCT02940054 ·Status: UNKNOWN
-
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice
NCT04890262 ·Status: COMPLETED
-
Zurich Fistula Cohort Study
NCT03003351 ·Status: UNKNOWN
-
Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease
NCT05874349 ·Status: COMPLETED
-
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
NCT06244849 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease
NCT03435016 ·Status: COMPLETED ·Phase: NA
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409 ·Status: UNKNOWN
-
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis
NCT02549976 ·Status: COMPLETED ·Phase: NA
-
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
NCT02130349 ·Status: UNKNOWN
-
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
NCT05596422 ·Status: COMPLETED
-
Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD
NCT06214299 ·Status: NOT_YET_RECRUITING
-
Advanced Therapy Registry of IBD Patients
NCT04998084 ·Status: UNKNOWN